title: Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.
authors.affiliation: Department of Dermatology, University of Pittsburgh School of Medicine , Pittsburgh, PA , USA.
authors.forename: Brittany O'Neill
authors.initials: BO
authors.lastname: Dulmage
authors.forename: Sara K
authors.initials: SK
authors.lastname: Story
authors.forename: Louis D
authors.initials: LD
authors.lastname: Falo
authors.forename: Larisa J
authors.initials: LJ
authors.lastname: Geskin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects*; D004249:DNA Damage / Q000187:drug effects*; D047630:Depsipeptides / Q000008:administration & dosage; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000473:pathology; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D008466:Mechlorethamine / Q000008:administration & dosage; D009367:Neoplasm Staging; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014407:Tumor Cells, Cultured
chemical_list: D047630:Depsipeptides; D008466:Mechlorethamine; C087123:romidepsin